Literature DB >> 34962573

Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors.

Laura van Iersel1, Renee L Mulder2, Christian Denzer3, Laurie E Cohen4,5,6, Helen A Spoudeas7,8,9, Lillian R Meacham10,11, Elaine Sugden12, Antoinette Y N Schouten-van Meeteren2, Eelco W Hoving2, Roger J Packer13, Gregory T Armstrong14, Sogol Mostoufi-Moab15, Aline M Stades16, Dannis van Vuurden2, Geert O Janssens2,17, Cécile Thomas-Teinturier18,19, Robert D Murray20,21, Natascia Di Iorgi22, Sebastian J C M M Neggers23, Joel Thompson24, Andrew A Toogood25, Helena Gleeson25, Cecilia Follin26, Edit Bardi27,28, Lilibeth Torno29, Briana Patterson10,11, Vera Morsellino30, Grit Sommer31,32, Sarah C Clement33, Deokumar Srivastava34, Cecilie E Kiserud35, Alberto Fernandez36, Katrin Scheinemann37,38,39, Sripriya Raman40, Kevin C J Yuen41, W Hamish Wallace42, Louis S Constine43, Roderick Skinner44, Melissa M Hudson45, Leontien C M Kremer2,46, Wassim Chemaitilly47, Hanneke M van Santen1.   

Abstract

Endocrine disorders in survivors of childhood, adolescent, and young adult (CAYA) cancers are associated with substantial adverse physical and psychosocial effects. To improve appropriate and timely endocrine screening and referral to a specialist, the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) aims to develop evidence and expert consensus-based guidelines for healthcare providers that harmonize recommendations for surveillance of endocrine disorders in CAYA cancer survivors. Existing IGHG surveillance recommendations for premature ovarian insufficiency, gonadotoxicity in males, fertility preservation, and thyroid cancer are summarized. For hypothalamic-pituitary (HP) dysfunction, new surveillance recommendations were formulated by a guideline panel consisting of 42 interdisciplinary international experts. A systematic literature search was performed in MEDLINE (through PubMed) for clinically relevant questions concerning HP dysfunction. Literature was screened for eligibility. Recommendations were formulated by drawing conclusions from quality assessment of all evidence, considering the potential benefits of early detection and appropriate management. Healthcare providers should be aware that CAYA cancer survivors have an increased risk for endocrine disorders, including HP dysfunction. Regular surveillance with clinical history, anthropomorphic measures, physical examination, and laboratory measurements is recommended in at-risk survivors. When endocrine disorders are suspected, healthcare providers should proceed with timely referrals to specialized services. These international evidence-based recommendations for surveillance of endocrine disorders in CAYA cancer survivors inform healthcare providers and highlight the need for long-term endocrine follow-up care in subgroups of survivors and elucidate opportunities for further research.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  childhood cancer survivor; clinical practice guidelines; endocrine complications; endocrine late effects; radiotherapy late effects

Mesh:

Year:  2022        PMID: 34962573     DOI: 10.1210/endrev/bnab040

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   25.261


  1 in total

1.  Expert Opinion on the Management of Growth Hormone Deficiency in Brain Tumor Survivors: Results From an Italian Survey.

Authors:  Natascia Di Iorgi; Giovanni Morana; Marco Cappa; Ludovico D'Incerti; Maria Luisa Garrè; Armando Grossi; Lorenzo Iughetti; Patrizia Matarazzo; Maria Parpagnoli; Gabriella Pozzobon; Mariacarolina Salerno; Iacopo Sardi; Malgorzata Gabriela Wasniewska; Stefano Zucchini; Andrea Rossi; Mohamad Maghnie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.